Categories Earnings, Health Care

ImmunoGen Inc (IMGN): Q4 2019 Earnings Snapshot

Earnings Update by AlphaStreet

— ImmunoGen Inc. (NASDAQ: IMGN) reported its fourth-quarter 2019 earnings of $0.03 per share vs $0.05 per share loss expected.  

— Revenue jumped threefold to $44.8 million, versus $29.3 million expected. The results were helped by higher license fees and lower operating expenses. 

— For fiscal 2020, company expects revenues between $60 million and $65 million. Operating expenses are projected to be between $165 million and $170 million.

— IMGN shares shot up 5.4% immediately following the announcement. 

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

FDX Earnings: All you need to know about FedEx’s Q1 2022 earnings results

FedEx Corporation (NYSE: FDX) reported first-quarter 2022 earnings results today. Total revenues increased to $22 billion from $19.3 billion in the same period a year ago. The company reported a

Adobe reports 22% spike in Q3 revenue: Infographic

Adobe Inc (NASDAQ: ADBE) reported third-quarter 2021 financial results after the regular market hours on Tuesday. The software giant reported Q3 revenue of $3.94 billion, up 22% year-over-year and higher

Starbucks (SBUX) Stock: Should you invest in the coffee giant now?

The restaurant and food service industry is struggling to regain momentum after being hit hard by the pandemic. Restauranteurs are currently busy adapting to the changed operating conditions, shifting focus

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top